Journal of Neuro-Oncology · 2023 · 13 citations · 40 references
MedicineMolecular GeneticsOncologyCancer GeneticsGene ExpressionMolecular OncologyBrain TumorsCancer GenomicsMalignant NeoplasmsNoncoding Rna BiologyNoncoding Rna In CancerPediatric Brain TumorsBcl-2 InhibitionCancer-related Noncoding Rna FunctionLong Non-coding Ribonucleic AcidsLong Non-coding Rna FunctionMedulloblastoma PathologyPediatric Brain Tumor BiologyPromoter Methylation
PURPOSE: Primary brain tumors are a leading cause of cancer-related death in children, and medulloblastoma is the most common malignant pediatric brain tumor. The current molecular characterization of medulloblastoma is mainly based on protein-coding genes, while little is known about the involvement of long non-coding RNAs (lncRNAs). This study aimed to elucidate the role of the lncRNA OTX2-AS1 in medulloblastoma. METHODS: Analyses of DNA copy number alterations, methylation profiles, and gene expression data were used to characterize molecular alterations of OTX2-AS1 in medulloblastoma tissue samples. In vitro analyses of medulloblastoma cell models and orthotopic in vivo experiments were carried out for functional characterization of OTX2-AS1. High-throughput drug screening was employed to identify pharmacological inhibitors, while proteomics and metabolomics analyses were performed to address potential mechanisms of drug action. RESULTS: We detected amplification and consecutive overexpression of OTX2 and OTX2-AS1 in a subset of medulloblastomas. In addition, OTX2-AS1 promoter methylation was linked to OTX2-AS1 expression. OTX2-AS1 knockout reduced medulloblastoma cell viability and cell migration in vitro and prolonged survival in the D283 orthotopic medulloblastoma mouse xenograft model. Pharmacological inhibition of BCL-2 suppressed the growth of OTX2-AS1 overexpressing medulloblastoma cells in vitro. CONCLUSIONS: Our study revealed a pro-tumorigenic role of OTX2-AS1 in medulloblastoma and identified BCL-2 inhibition as a potential therapeutic approach to target OTX2-AS1 overexpressing medulloblastoma cells.
40
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor, Paul A. Northcott, Andrey Korshunov et al. · Acta Neuropathologica · 2011 · 2K citations · Full text
The economic cost of brain disorders in Europe
Jes Olesen, Anders Gustavsson, Mikael Svensson et al. · European Journal of Neurology · 2011 · 1.5K citations
Medicine, Neurology, Psychiatry +17
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek et al. · Cancer Cell · 2017 · 1.3K citations · Full text
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott, David Shih, John Peacock et al. · Nature · 2012 · 921 citations · Full text